Literature DB >> 93747

Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.

J Geller, J Albert, D Nachtsheim, D Loza, S Lippman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93747

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  19 in total

1.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

2.  Microassay for prostatic androgen receptors correlated with quantitative histological assessment.

Authors:  S M Widdowson; J L Ostrowski; V J Dangerfield; S C Harris; P M Ingleton; J C Underwood; J L Williams; M A Parsons
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

3.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.

Authors:  Jonathan L Wright; Erika M Kwon; Elaine A Ostrander; R Bruce Montgomery; Daniel W Lin; Robert Vessella; Janet L Stanford; Elahe A Mostaghel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

Review 4.  Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum.

Authors:  Leonardo Oliveira Reis
Journal:  Med Oncol       Date:  2011-05-28       Impact factor: 3.064

Review 5.  Androgen action and metabolism in prostate cancer.

Authors:  Sean M Green; Elahe A Mostaghel; Peter S Nelson
Journal:  Mol Cell Endocrinol       Date:  2012-03-20       Impact factor: 4.102

Review 6.  A brief history of intracrine androgen metabolism by castration-recurrent prostate cancer.

Authors:  James L Mohler
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 7.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

8.  Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.

Authors:  Bruce Montgomery; Peter S Nelson; Robert Vessella; Tom Kalhorn; David Hess; Eva Corey
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

Review 9.  The basic biochemistry and molecular events of hormone therapy.

Authors:  Elahe A Mostaghel; Robert B Montgomery; Daniel W Lin
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

10.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Authors:  R Bruce Montgomery; Elahe A Mostaghel; Robert Vessella; David L Hess; Thomas F Kalhorn; Celestia S Higano; Lawrence D True; Peter S Nelson
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.